Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-05-29

FDA Approved: MIRENA — Supplemental Application (Bayer HealthCare Pharmaceuticals Inc.)

View source ↗

Summary

The FDA has approved a supplemental application for MIRENA (levonorgestrel) submitted by Bayer HealthCare Pharmaceuticals.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mirena (levonorgestrel-releasing intrauterine system)

Snippet

SUPPL AP for MIRENA (LEVONORGESTREL)